Page last updated: 2024-08-17

cytidine monophosphate and Granulocytic Leukemia

cytidine monophosphate has been researched along with Granulocytic Leukemia in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19902 (40.00)18.7374
1990's2 (40.00)18.2507
2000's1 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kamiya, K; Kawai, Y; Nakamura, T; Sugiyama, M; Tsutani, H; Ueda, T; Urasaki, Y; Wataya, S1
Braess, J; Freund, M; Hanauske, A; Heil, G; Hiddemann, W; Kaufmann, C; Kern, W; Schleyer, E; Schüssler, M1
Leen, R; van Gennip, AH; van Kuilenburg, AB; Verschuur, AC; Voûte, PA1
Drake, WP; Kopyta, LP; Levy, CC; Mardiney, MR1
Bianchi, U; Calabrese, G; Ferrucci, L; Guanciali-Franchi, P; Mezzanotte, R; Palka, G; Stuppia, R; Sumner, AT; Vanni, R1

Trials

1 trial(s) available for cytidine monophosphate and Granulocytic Leukemia

ArticleYear
Oral cytarabine ocfosfate in acute myeloid leukemia and non-Hodgkin's lymphoma--phase I/II studies and pharmacokinetics.
    Leukemia, 1998, Volume: 12, Issue:10

    Topics: Acute Disease; Administration, Oral; Adult; Antineoplastic Agents; Arabinonucleotides; Biological Availability; Cytarabine; Cytidine Monophosphate; Diarrhea; Dose-Response Relationship, Drug; Half-Life; Humans; Infusions, Intravenous; Leukemia, Myeloid; Lymphoma, Non-Hodgkin; Metabolic Clearance Rate; Prodrugs; Regression Analysis

1998

Other Studies

4 other study(ies) available for cytidine monophosphate and Granulocytic Leukemia

ArticleYear
Clinical pharmacology of 1-beta-D-arabinofuranosylcytosine-5'-stearylphosphate, an orally administered long-acting derivative of low-dose 1-beta-D-arabinofuranosylcytosine.
    Cancer research, 1994, Jan-01, Volume: 54, Issue:1

    Topics: Acute Disease; Adult; Aged; Anemia, Refractory, with Excess of Blasts; Antineoplastic Agents; Arabinonucleotides; Cytidine Monophosphate; Female; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Male; Middle Aged; Polycythemia Vera

1994
Cyclopentenyl cytosine increases the phosphorylation and incorporation into dna of arabinofu-ranosyl cytosine in a myeloid leukemic cell-line.
    Advances in experimental medicine and biology, 2000, Volume: 486

    Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Carbon-Nitrogen Ligases; Cytarabine; Cytidine; Cytidine Diphosphate; Cytidine Monophosphate; Deoxycytosine Nucleotides; DNA; Dose-Response Relationship, Drug; Enzyme Inhibitors; HL-60 Cells; Humans; Leukemia, Myeloid; Phosphorylation

2000
Alterations in ribonuclease activities in the plasma, spleen, and thymus of tumor-bearing mice.
    Cancer research, 1975, Volume: 35, Issue:2

    Topics: Adenocarcinoma; Adenosine Monophosphate; Animals; Cell Line; Cytidine Monophosphate; Leukemia, Myeloid; Lymphoma, Non-Hodgkin; Melanoma; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Neoplasm Proteins; Neoplasm Transplantation; Neoplasms, Experimental; Ribonucleases; Sarcoma, Experimental; Spleen; Thymus Gland; Transplantation, Homologous; Uridine Monophosphate

1975
Effect of HpaII and MspI restriction endonucleases on chronic myelogenous leukemia chromosomes. Detection of CpG dinucleotide demethylation in situ.
    Cancer genetics and cytogenetics, 1988, Volume: 34, Issue:2

    Topics: Cytidine Monophosphate; Cytosine Nucleotides; Deoxyribonuclease HpaII; Dinucleoside Phosphates; DNA Restriction Enzymes; DNA, Neoplasm; Guanosine; Humans; Karyotyping; Leukemia, Myeloid; Staining and Labeling

1988